Technical Articles
Multiple Myeloma
FITC-Labeled CD38 Fc Chimera Protein: Decoding the Core Fluorescent Probe for Immunomodulation, Cancer, and Aging Research
FITC-Labeled CD38 Fc Chimera is a recombinant protein tool that combines the extracellular domain of human CD38 with the Fc fragment of immunoglobulin G (IgG) and is labeled with fluorescein isothiocyanate (FITC). As a specific detection probe for the multifunctional immunomodulatory receptor CD38, it is non-pathogenic but serves as a core experimental reagent in key disease research areas such as multiple myeloma, autoimmune diseases, metabolic disorders, viral infections, and age-related immune decline.
View details
- Cancer
- CD38 Protein
- FITC-Labeled
- Fc Fusion Protein
- Multiple Myeloma
- Daratumumab
- Flow Cytometry
FITC-Labeled SLAMF7/CRACC/CD319 Fc Chimera Protein: A Green Navigation Beacon for Immunotherapy in Multiple Myeloma
FITC-Labeled SLAMF7/CRACC/CD319 Fc Chimera Protein is a high-performance fluorescently labeled fusion protein with critical value in immunotherapy research for hematologic malignancies such as multiple myeloma.
View details
- Cancer
- SLAMF7/CRACC/CD319
- Fc Chimera
- Multiple Myeloma
- Hematologic Malignancies
Decoding Key Probes for the Diagnosis and Treatment of Multiple Myeloma
FITC-Labeled Syndecan-1/CD138 His Tag protein is an advanced fluorescently labeled tool protein that plays a significant role in the study of diseases such as multiple myeloma.
View details
- Cancer
- FITC-Labeled Syndecan-1/CD138 His Tag
- Multiple Myeloma
- Fluorescently Labeled Tool Protein
- 1














